Faraday Pharmaceuticals, Inc.
Clinical trials sponsored by Faraday Pharmaceuticals, Inc., explained in plain language.
-
New drug aims to prevent dangerous heart rhythms after heart attack
Disease control CompletedThis study tested an experimental drug called FDY-5301 in 120 people having a severe heart attack (STEMI). The goal was to see if the drug could reduce dangerous heart rhythm problems and limit heart muscle damage compared to a placebo. Participants received the drug or placebo b…
Phase: PHASE2 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug aims to save hearts after massive attacks
Disease control CompletedThis study tested an experimental drug called FDY 5301 in over 2,300 people who had a severe type of heart attack (anterior STEMI) and were undergoing emergency artery-opening treatment. The goal was to see if the drug could lower the chance of dying from heart problems or develo…
Phase: PHASE3 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC